Eli Lilly and Co. CEO Dave Ricks said he was encouraged by President Donald Trump’s understanding of the complexities of drug development, yet he’s concerned about risks the industry may face in a fresh overhaul of the U.S. health-care system.
The company’s quarterly earnings announcement did not mention any new developments in the insurer’s pending, $54 billion acquisition of Cigna—which is under review by a federal judge.
For drugmakers, including Indianapolis-based Eli Lilly and Co., a meeting Tuesday with President Donald Trump was a dose of happy pills.
The NCAA and helmet maker Riddell are defendants in separate class-action lawsuits alleging they failed to protect football players from long-term head injuries and didn't educate them about the risks.
President Trump took Big Pharma to task on pricing but also promised to ease regulations and find ways to speed medicines to market, which triggered a surge in the sector’s share prices.
The Indianapolis-based drugmaker got a revenue boost from a host of new medications but also saw sales fall sharply for some older products.
Indiana now has one of the lowest cigarette taxes in the nation. It also has one of the highest smoking rates. Some groups want to decrease the latter in part by raising the former.
When the Indiana Legislature allowed a Senate committee to hear testimony on a medical marijuana-related bill, some proponents saw a glimmer of hope.
Dr. Tristan Stonger is accused of operating a “pill mill” in Peru, where he saw as many as 100 patients in a single day. He also had offices in Bloomington and Indianapolis.
Planned Parenthood of Indiana and Kentucky Inc. is searching for a new president and CEO to succeed Betty Cockrum, who plans to retire in June.
The chief medical officer for Indiana's prison system held an overlapping position with a for-profit Illinois company that provides health care to correctional facilities in more than a dozen states, according to a published report.
A former executive at an Indianapolis-based chain of health clinics says he was fired because of his age, race and national origin, and in retaliation because he stood up for one of his female managers.
The Indianapolis-based drugmaker’s purchase of the biotech firm CoLucid Pharmaceuticals will give it access to a late-stage experimental medication for migraine headaches.
Purdue University Professor You-Yeon Won’s development, called radio-luminescent nanoparticles, is designed to enhance the cancer-cell-killing effects of radiation treatment.
Doctors are reporting more burnout because of too many bureaucratic tasks, difficult patients and too many hours at work. But not all specialties are hit equally hard.
The wrecking ball is busy at Community Hospital East, knocking down one building after another, as workers ready the site for a brand-new, $175 million hospital.
Teva Pharmaceuticals Industries Ltd.’s proposed generic version infringes a patent on the multi-billion-dollar patent, the U.S. Court of Appeals for the Federal Circuit ruled.
By a near party-line 51-48 vote early Thursday, the GOP-run Senate approved a budget that eases the way for action on subsequent repeal legislation as soon as next month.
Green Circle Health's client services center will provide remote health care and coaching for customers across the country, focusing in part on improving the coordination of care for chronic diseases.
A small Carmel-based biotech firm has signed a deal with international drug company Allergan Plc that is worth at least $50 million and could grow to more than $2 billion under the best-case scenario.
